NewsBenzinga모건스탠리, 버 바이오테크놀로지 투자의견 ‘비중확대’ 유지···목표주가 28달러로 상향 모건스탠리, 버 바이오테크놀로지 투자의견 ‘비중확대’ 유지···목표주가 28달러로 상향 Benzinga 2026.11.10 17:26 (GMT+0) Open on Benzinga Other news ‘Nvidia Is an Unbelievably Important Technology Company’: CoreWeave’s Michael Intrator Is Shrugging Off Jensen Huang’s Scandal — ‘You Know We Continue to Work With Them Closely’ Apple reveals new Mac security controls as AI agents raise privacy risks US Stocks Close: Optical Module/High-Speed Interconnect and Neocloud Stocks Slump; Bitdeer Group Falls Over 19% Tom Lee Blames Nvidia and Anthropic IPO for Ethereum Plunge as Bitmine Buys the Dip Canaccord Genuity Maintains Buy on Belite Bio, Raises Price Target to $314 Applied Optoelectronics Stock Sinks Amid AI Outlook Fears
‘Nvidia Is an Unbelievably Important Technology Company’: CoreWeave’s Michael Intrator Is Shrugging Off Jensen Huang’s Scandal — ‘You Know We Continue to Work With Them Closely’
US Stocks Close: Optical Module/High-Speed Interconnect and Neocloud Stocks Slump; Bitdeer Group Falls Over 19%